GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 63.34
+0.34 (0.54%)
At close: Dec 2, 2025
GlaxoSmithKline S.A.E Revenue
GlaxoSmithKline S.A.E had revenue of 1.01B EGP in the quarter ending September 30, 2025, with 28.09% growth. This brings the company's revenue in the last twelve months to 3.74B, up 33.27% year-over-year. In the year 2024, GlaxoSmithKline S.A.E had annual revenue of 2.99B with 33.51% growth.
Revenue (ttm)
3.74B
Revenue Growth
+33.27%
P/S Ratio
1.41
Revenue / Employee
4.68M
Employees
800
Market Cap
5.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.99B | 750.60M | 33.51% |
| Dec 31, 2023 | 2.24B | 416.99M | 22.87% |
| Dec 31, 2022 | 1.82B | 11.19M | 0.62% |
| Dec 31, 2021 | 1.81B | -180.79M | -9.07% |
| Dec 31, 2020 | 1.99B | 288.80M | 16.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| El Sewedy Electric Company | 266.87B |
| Commercial International Bank Egypt (CIB) S.A.E. | 124.00B |
| Telecom Egypt Company | 101.94B |
| Talaat Moustafa Group Holding | 53.03B |
| Qatar National Bank | 50.63B |
| Egypt Aluminum | 43.18B |
| Eastern Company S.A.E | 37.38B |
| Misr Fertilizer Production Company | 25.16B |